vs
Side-by-side financial comparison of ARGENX SE (ARGX) and Avery Dennison (AVY). Click either name above to swap in a different company.
ARGENX SE is the larger business by last-quarter revenue ($2.5B vs $2.3B, roughly 1.1× Avery Dennison). ARGENX SE runs the higher net margin — 35.5% vs 7.3%, a 28.2% gap on every dollar of revenue. On growth, ARGENX SE posted the faster year-over-year revenue change (83.2% vs 7.0%). ARGENX SE produced more free cash flow last quarter ($322.4M vs $104.4M).
AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.
Avery Dennison Corporation is an American multinational manufacturer and distributor of pressure-sensitive adhesive materials, apparel branding labels and tags, RFID inlays, and specialty medical products. The company is a member of the Fortune 500 and is headquartered in Mentor, Ohio.
ARGX vs AVY — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $2.5B | $2.3B |
| Net Profit | $877.2M | $168.1M |
| Gross Margin | 89.5% | 28.9% |
| Operating Margin | 28.9% | 10.7% |
| Net Margin | 35.5% | 7.3% |
| Revenue YoY | 83.2% | 7.0% |
| Net Profit YoY | 1.3% | 1.1% |
| EPS (diluted) | $13.25 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $2.3B | ||
| Q4 25 | $2.5B | $2.3B | ||
| Q3 25 | — | $2.2B | ||
| Q2 25 | $1.8B | $2.2B | ||
| Q1 25 | — | $2.1B | ||
| Q4 24 | $1.4B | $2.2B | ||
| Q3 24 | — | $2.2B | ||
| Q2 24 | $901.9M | $2.2B |
| Q1 26 | — | $168.1M | ||
| Q4 25 | $877.2M | $166.4M | ||
| Q3 25 | — | $166.3M | ||
| Q2 25 | $414.8M | $189.0M | ||
| Q1 25 | — | $166.3M | ||
| Q4 24 | $865.6M | $174.0M | ||
| Q3 24 | — | $181.7M | ||
| Q2 24 | $-32.5M | $176.8M |
| Q1 26 | — | 28.9% | ||
| Q4 25 | 89.5% | 28.7% | ||
| Q3 25 | — | 28.7% | ||
| Q2 25 | 89.2% | 28.8% | ||
| Q1 25 | — | 28.9% | ||
| Q4 24 | 90.2% | 27.9% | ||
| Q3 24 | — | 28.7% | ||
| Q2 24 | 89.4% | 29.6% |
| Q1 26 | — | 10.7% | ||
| Q4 25 | 28.9% | 9.1% | ||
| Q3 25 | — | 10.6% | ||
| Q2 25 | 19.2% | 11.5% | ||
| Q1 25 | — | 10.6% | ||
| Q4 24 | 8.7% | 11.0% | ||
| Q3 24 | — | 11.0% | ||
| Q2 24 | -15.4% | 10.7% |
| Q1 26 | — | 7.3% | ||
| Q4 25 | 35.5% | 7.3% | ||
| Q3 25 | — | 7.5% | ||
| Q2 25 | 23.4% | 8.5% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | 64.1% | 8.0% | ||
| Q3 24 | — | 8.3% | ||
| Q2 24 | -3.6% | 7.9% |
| Q1 26 | — | — | ||
| Q4 25 | $13.25 | $2.16 | ||
| Q3 25 | — | $2.13 | ||
| Q2 25 | $6.32 | $2.41 | ||
| Q1 25 | — | $2.09 | ||
| Q4 24 | $13.33 | $2.17 | ||
| Q3 24 | — | $2.25 | ||
| Q2 24 | $-0.55 | $2.18 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.5B | $255.1M |
| Total DebtLower is stronger | — | $3.2B |
| Stockholders' EquityBook value | $7.3B | $2.3B |
| Total Assets | $8.7B | $9.0B |
| Debt / EquityLower = less leverage | — | 1.38× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $255.1M | ||
| Q4 25 | $3.5B | $202.8M | ||
| Q3 25 | — | $536.3M | ||
| Q2 25 | $2.1B | $215.9M | ||
| Q1 25 | — | $195.9M | ||
| Q4 24 | $1.5B | $329.1M | ||
| Q3 24 | — | $212.7M | ||
| Q2 24 | $1.4B | $208.8M |
| Q1 26 | — | $3.2B | ||
| Q4 25 | — | $3.2B | ||
| Q3 25 | — | $3.2B | ||
| Q2 25 | — | $2.6B | ||
| Q1 25 | — | $2.6B | ||
| Q4 24 | — | $2.6B | ||
| Q3 24 | — | $2.0B | ||
| Q2 24 | $11.0M | $2.0B |
| Q1 26 | — | $2.3B | ||
| Q4 25 | $7.3B | $2.2B | ||
| Q3 25 | — | $2.2B | ||
| Q2 25 | $6.1B | $2.2B | ||
| Q1 25 | — | $2.2B | ||
| Q4 24 | $5.5B | $2.3B | ||
| Q3 24 | — | $2.4B | ||
| Q2 24 | $4.3B | $2.3B |
| Q1 26 | — | $9.0B | ||
| Q4 25 | $8.7B | $8.8B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | $7.2B | $8.6B | ||
| Q1 25 | — | $8.4B | ||
| Q4 24 | $6.2B | $8.4B | ||
| Q3 24 | — | $8.5B | ||
| Q2 24 | $4.8B | $8.3B |
| Q1 26 | — | 1.38× | ||
| Q4 25 | — | 1.43× | ||
| Q3 25 | — | 1.45× | ||
| Q2 25 | — | 1.19× | ||
| Q1 25 | — | 1.19× | ||
| Q4 24 | — | 1.11× | ||
| Q3 24 | — | 0.85× | ||
| Q2 24 | 0.00× | 0.89× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $323.3M | — |
| Free Cash FlowOCF − Capex | $322.4M | $104.4M |
| FCF MarginFCF / Revenue | 13.0% | 4.5% |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | 0.37× | — |
| TTM Free Cash FlowTrailing 4 quarters | $594.5M | $869.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $323.3M | $376.8M | ||
| Q3 25 | — | $312.1M | ||
| Q2 25 | $361.8M | $208.8M | ||
| Q1 25 | — | $-16.3M | ||
| Q4 24 | $41.9M | $351.2M | ||
| Q3 24 | — | $270.1M | ||
| Q2 24 | $-124.7M | $197.7M |
| Q1 26 | — | $104.4M | ||
| Q4 25 | $322.4M | $309.7M | ||
| Q3 25 | — | $276.2M | ||
| Q2 25 | $356.6M | $178.8M | ||
| Q1 25 | — | $-52.3M | ||
| Q4 24 | $40.9M | $281.7M | ||
| Q3 24 | — | $227.1M | ||
| Q2 24 | $-125.5M | $150.2M |
| Q1 26 | — | 4.5% | ||
| Q4 25 | 13.0% | 13.6% | ||
| Q3 25 | — | 12.5% | ||
| Q2 25 | 20.1% | 8.1% | ||
| Q1 25 | — | -2.4% | ||
| Q4 24 | 3.0% | 12.9% | ||
| Q3 24 | — | 10.4% | ||
| Q2 24 | -13.9% | 6.7% |
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | 3.0% | ||
| Q3 25 | — | 1.6% | ||
| Q2 25 | 0.3% | 1.4% | ||
| Q1 25 | — | 1.7% | ||
| Q4 24 | 0.1% | 3.2% | ||
| Q3 24 | — | 2.0% | ||
| Q2 24 | 0.1% | 2.1% |
| Q1 26 | — | — | ||
| Q4 25 | 0.37× | 2.26× | ||
| Q3 25 | — | 1.88× | ||
| Q2 25 | 0.87× | 1.10× | ||
| Q1 25 | — | -0.10× | ||
| Q4 24 | 0.05× | 2.02× | ||
| Q3 24 | — | 1.49× | ||
| Q2 24 | — | 1.12× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ARGX
Segment breakdown not available.
AVY
| Materials Group | $1.6B | 72% |
| Solutions Group | $649.2M | 28% |
